Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · page 11 of 50
The Venn diagram shows the intersection of genetic targets (TL1A, IL-23, a4b7). The bar chart compares 'All-comers' vs 'CDx+' (companion diagnostic positive) patient groups for two drugs (PRA023 and RVT-3101).
Deck · key_takeaways · cite_precedent · balanced density
Slide locked Sign in to view
Slide schematic 4/4
chart 1/1 diagram 1/1 metric 1/1 title 1/1
Components 4
bar-grouped venn big-number headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1